SCHEMBL2448764

SCHEMBL2448764

O=C(O)[C@@H]1CCC(=O)N1Cc1cccc(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 8/20 0.58
TP53 P04637 1/20 0.53
MDM2 Q00987 1/20 0.53
GYS1 P13807 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C19 P33261 1/20 0.49
USP2 O75604 1/20 0.48
SIGMAR1 Q99720 1/20 0.47
MAPT P10636 2/20 0.47
HTT P42858 2/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL288849 1.00 P2RX7 (0.58) P2RX7TP53MDM2GYS1CYP1A2
SCHEMBL1612852 1.00 P2RX7 (0.58) P2RX7TP53MDM2GYS1CYP1A2
SCHEMBL30061816 1.00 P2RX7 (0.58) P2RX7TP53MDM2GYS1CYP1A2
SCHEMBL28021326 0.91 P2RX7 (0.57) P2RX7TP53MDM2CYP1A2CYP3A4
SCHEMBL19974972 0.90 P2RX7 (0.56) P2RX7TP53MDM2CYP1A2CYP3A4
SCHEMBL16328230 0.88 P2RX7 (0.60) P2RX7TP53MDM2CYP1A2CYP3A4
SCHEMBL288651 0.87 P2RX7 (0.56) P2RX7GYS1CYP3A4CYP2D6CYP2C9
SCHEMBL289574 0.87 P2RX7 (0.56) P2RX7GYS1CYP3A4CYP2D6CYP2C9
SCHEMBL288652 0.87 P2RX7 (0.56) P2RX7GYS1CYP3A4CYP2D6CYP2C9
SCHEMBL10377790 0.86 P2RX7 (0.60) P2RX7TP53MDM2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed